HES
49
2
O
26
16
CI
35
2
DHI
36
3
EA
41
3
FTI
61
5
BIIB
36
8
CCI
30
2
VTR
44
4
IVZ
42
13
PLD
35
5
PCG
59
9
ROST
60
3
RRC
52
2
DGX
28
4
MTB
38
4
ALL
37
3
WMB
58
3
NDAQ
46
2
GD
42
4
HES
49
2
O
26
16
CI
35
2
DHI
36
3
EA
41
3
FTI
61
5
BIIB
36
8
CCI
30
2
VTR
44
4
IVZ
42
13
PLD
35
5
PCG
59
9
ROST
60
3
RRC
52
2
DGX
28
4
MTB
38
4
ALL
37
3
WMB
58
3
NDAQ
46
2
GD
42
4
Financhill
Back

Wilmar International Vs. Kymera Therapeutics Industry Stock Comparison

Sell
47

WLMIY
Wilmar International

Last Price:
$22.23
Seasonality Move:
2.32%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.75
Seasonality Move:
2.79%
Sell
47
Wilmar International (WLMIY) is a Sell

Is Wilmar International a Buy, Sell or Hold?

  • The current Wilmar International [WLMIY] share price is $22.18. The Score for WLMIY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • WLMIY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.64. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WLMIY Stock Price Chart

What is Wilmar International's stock price today?

  • The Wilmar International share price today is $22.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WLMIY is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

WLMIY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 38.31 Sell
Chaikin Money Flow: -7882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.47 - 23.21) Sell
Bollinger Bands (100): (22.99 - 25.05) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.07 Sell
Chaikin Money Flow: 1023886 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.59 - 46.41) Sell
Bollinger Bands (100): (42.92 - 48.78) Sell

WLMIY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.47 Sell
20-day SMA: 22.79 Sell
50-day SMA: 23.58 Sell
200-day SMA: 24.03 Sell
8-day EMA: 22.41 Sell
20-day EMA: 22.75 Sell
50-day EMA: 23.33 Sell
200-day EMA: 24.22 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.68 Sell
20-day SMA: 44.26 Sell
50-day SMA: 45.89 Sell
200-day SMA: 41.31 Sell
8-day EMA: 41.51 Sell
20-day EMA: 43.39 Sell
50-day EMA: 44.87 Sell
200-day EMA: 41.09 Sell

Wilmar International Earnings Growth & WLMIY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Wilmar International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):